Plain-English translation of NCT07231497 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Researchers are studying how the brain responds to different thinking strategies in people who are experiencing early psychosis. This trial will use brain imaging (called EEG) and computer-based thinking tasks to measure brain activity while participants are given , a medication that helps with alertness and focus. The study aims to understand whether this medication combined with certain thinking strategies can help improve cognitive function in early psychosis.
People with early psychosis often struggle with thinking, concentration, and memory. Researchers want to learn whether this medication and specific thinking strategies can help improve these cognitive problems and understand exactly how they work in the brain.
You likely qualify if…
You likely don't qualify if…
You would attend two appointments about one week apart. The first appointment (30 minutes to 2.5 hours) includes an interview about your medical and mental health history, some questionnaires, and computer-based thinking games. The second appointment (about 4–4.5 hours) includes safety screening with blood tests and a urine sample, then you'll have a special cap placed on your head to measure brain activity (EEG) while you complete more thinking tasks after taking the study medication.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
United States